Goodwin’s Antitrust and Competition practice has represented Beth Israel Deaconess Medical Center and Lahey Health System and all associated parties in an exhaustive federal and state investigation, which has concluded today with the regulators’ approval.
The merger, which The Boston Globe called “the most significant health care deal in Massachusetts” in decades, will create a transformative healthcare system in the greater Boston area.
Goodwin also handled the Second Request for all of five parties to the merger (CareGroup, Inc., Lahey Health System, Inc., Seacoast Regional Health Systems, Inc., BIDCO Physician LLC, and BIDCO Hospital LLC) as the lone antitrust counsel.
The Goodwin team was led by partner Paul Jin and senior discovery attorney Danielle Panetta.
For additional information, please read the press release from the Federal Trade Commission, and the press release from the Office of Attorney General Maura Healey.